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Background
The targeted integration of transgenes into a pre-
characterized genomic locus enables predictable pro-
tein expression to occur, which reduces the need for
the screening of transfected clones. We previously
developed an accumulative site-specific gene integra-
tion system (AGIS), which enabled the repeated inte-
gration of multiple transgenes into a pre-determined
locus of the cell genome [1,2]. We achieved the
repeated integration of recombinant scFv-Fc gene into
the genome of Chinese hamster ovary (CHO) cells, a
common animal host cell for the production of recom-
binant biopharmaceutical proteins. Productivity was
shown to correspond to the copy number of the expres-
sion cassette [3]. Cell screening after gene transfection
was the most time-consuming process in AGIS, but we
hypothesized that the use of fluorescent selection mar-
kers instead of drug resistant genes would facilitate the
cell establishment process because Cre-mediated inte-
gration is completed within 48 h post-transfection.
Therefore, the present study used marker genes encod-
ing fluorescent proteins to speed up the establishment
of producer CHO cells using AGIS.
Materials and methods
We constructed a donor plasmid encoding a DsRed gene
upstream of a scFv-Fc expression unit flanked by a wild-
type loxP and a mutated loxP (P2R-scFvFc). An insulator
element derived from the CHO cell genome was located
either side of the scFv-Fc expression cassette. Recombi-
nant CHO cells (CHO/P1G) containing EGFP flanked by
compatible target sites were used as founder cells [4].
CHO/P1G cells were seeded at 1.2 × 105 cells per well of
24-well plates, and the donor plasmid and a Cre expres-
sion vector (pCEP4/NCre) were co-transfected into
the founder cells the next day using Lipofectamine 2000
(Life Technologies) according to the manufacturer’s
instructions. After 48 h, transfected cells were seeded at
2,400 cells per 100-mm dish. Colonies exhibiting a shift
in fluorescence from green to red were identified by
fluorescence-activated cell sorting (FACS) to establish
cell clones. Transgene integration into the cells was con-
firmed by genomic PCR analysis. The viable cell density
was determined by the trypan blue exclusion method.
Recombinant scFv-Fc concentration was measured
by ELISA.
Results and discussion
Following transfection of the donor plasmid with a Cre
expression vector (5 ng) into founder cells, we screened
recombinant cells exhibiting a fluorescent color shift
from green to red via the Cre/loxP reaction (Figure 1A).
A total of 44.4% of colonies exhibited an incomplete
fluorescence shift, with some DsRed/EGFP double posi-
tive cells or weakly DsRed-positive cells observed. A
two-step recombination reaction took place, involving
the appearance of intermediate clones in a Cre-recombi-
nase mediated cassette exchange (RMCE) reaction, as
shown in Figure 1B. Thus, an increased amount of the
Cre expression vector increased the number of DsRed-
positive colonies, reducing the population of incomplete
colonies. When 50 ng of Cre expression vector was
used, the maximum integration efficiency for complete
clones was observed (84.1%) (Figure 1C). The integra-
tion efficiency decreased when >50 ng Cre expression
vector was used because of its cytotoxicity. For
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established clones (CHO/P2R-scFvFc), transgene inte-
gration into the expected chromosomal site was con-
firmed by genomic PCR and sequencing of amplicons.
No significant difference in cell growth was observed
among the clones. They also exhibited similar levels of
scFv-Fc productivity and a similar fluorescence profile.
Cells harboring scFv-Fc expression units flanked by
insulator elements showed higher and more stable scFv-
Fc productivity compared with those without the insula-
tor insertion.
Figure 1 Targeted transgene integration for CHO cells using Cre/loxP. A: Schematic of Cre-RMCE in CHO/P1G cells. B: Intermediate clonal
forms during Cre-RMCE. C: Colony numbers undergoing a shift in fluorescence
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Conclusions
Transgenes were integrated into a predetermined chro-
mosomal locus of CHO cells using AGIS. The rapid
screening of recombinant cells using a FACS device was
based on a shift in fluorescence. RMCE-completed
clones exhibited similar levels of scFv-Fc productivity
and fluorescent protein expression. Moreover, higher
and more stable scFv-Fc production was achieved using
the insulator insertion.
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